Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

Europe - EPA:ALTUV - FR0013345493 - Common Stock

1.578 EUR
+0 (+0.25%)
Last: 11/20/2025, 7:00:00 PM
Fundamental Rating

4

Overall ALTUV gets a fundamental rating of 4 out of 10. We evaluated ALTUV against 102 industry peers in the Machinery industry. Both the profitability and the financial health of ALTUV get a neutral evaluation. Nothing too spectacular is happening here. ALTUV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALTUV had positive earnings in the past year.
In the past year ALTUV had a positive cash flow from operations.
In the past 5 years ALTUV has always been profitable.
ALTUV had a positive operating cash flow in 4 of the past 5 years.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

ALTUV has a Return On Assets of 1.36%. This is in the lower half of the industry: ALTUV underperforms 63.73% of its industry peers.
ALTUV has a worse Return On Equity (2.41%) than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.84%, ALTUV is doing worse than 69.61% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALTUV is below the industry average of 8.41%.
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROIC 2.84%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 2.64%, ALTUV is in line with its industry, outperforming 43.14% of the companies in the same industry.
In the last couple of years the Profit Margin of ALTUV has declined.
ALTUV's Operating Margin of 5.93% is in line compared to the rest of the industry. ALTUV outperforms 48.04% of its industry peers.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
ALTUV has a Gross Margin of 38.14%. This is comparable to the rest of the industry: ALTUV outperforms 44.12% of its industry peers.
ALTUV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTUV is destroying value.
The number of shares outstanding for ALTUV has been reduced compared to 1 year ago.
ALTUV has more shares outstanding than it did 5 years ago.
ALTUV has a better debt/assets ratio than last year.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that ALTUV is in the distress zone and has some risk of bankruptcy.
ALTUV has a Altman-Z score of 1.45. This is in the lower half of the industry: ALTUV underperforms 63.73% of its industry peers.
ALTUV has a debt to FCF ratio of 7.69. This is a slightly negative value and a sign of low solvency as ALTUV would need 7.69 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.69, ALTUV is in line with its industry, outperforming 42.16% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that ALTUV is not too dependend on debt financing.
ALTUV has a Debt to Equity ratio (0.39) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Altman-Z 1.45
ROIC/WACC0.41
WACC6.9%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ALTUV has a Current Ratio of 2.05. This indicates that ALTUV is financially healthy and has no problem in meeting its short term obligations.
ALTUV's Current ratio of 2.05 is fine compared to the rest of the industry. ALTUV outperforms 77.45% of its industry peers.
A Quick Ratio of 1.31 indicates that ALTUV should not have too much problems paying its short term obligations.
ALTUV has a Quick ratio of 1.31. This is in the better half of the industry: ALTUV outperforms 74.51% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.31
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 195.24% over the past year.
The earnings per share for ALTUV have been decreasing by -64.42% on average. This is quite bad
Looking at the last year, ALTUV shows a decrease in Revenue. The Revenue has decreased by -7.99% in the last year.
Measured over the past years, ALTUV shows a quite strong growth in Revenue. The Revenue has been growing by 14.65% on average per year.
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%

3.2 Future

ALTUV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.51% yearly.
Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.54, ALTUV is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as ALTUV.
When comparing the Price/Earnings ratio of ALTUV to the average of the S&P500 Index (25.07), we can say ALTUV is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 15.32, the valuation of ALTUV can be described as correct.
ALTUV's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ALTUV to the average of the S&P500 Index (34.08), we can say ALTUV is valued rather cheaply.
Industry RankSector Rank
PE 22.54
Fwd PE 15.32
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALTUV is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALTUV indicates a somewhat cheap valuation: ALTUV is cheaper than 79.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.13
EV/EBITDA 9.07
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

ALTUV's earnings are expected to grow with 14.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%

3

5. Dividend

5.1 Amount

ALTUV has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
ALTUV's Dividend Yield is a higher than the industry average which is at 2.49.
ALTUV's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

BIO-UV GROUP SAS

EPA:ALTUV (11/20/2025, 7:00:00 PM)

1.578

+0 (+0.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-18 2025-09-18
Earnings (Next)01-22 2026-01-22/amc
Inst Owners6.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.33M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target3.06 (93.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)40%
EPS NY rev (3m)-64.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.2%
Valuation
Industry RankSector Rank
PE 22.54
Fwd PE 15.32
P/S 0.59
P/FCF 8.13
P/OCF 4.68
P/B 0.54
P/tB 4.35
EV/EBITDA 9.07
EPS(TTM)0.07
EY4.44%
EPS(NY)0.1
Fwd EY6.53%
FCF(TTM)0.19
FCFY12.3%
OCF(TTM)0.34
OCFY21.35%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROCE 3.87%
ROIC 2.84%
ROICexc 2.84%
ROICexgc 7.55%
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
FCFM 7.26%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Debt/EBITDA 3.38
Cap/Depr 79.6%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 99.7%
Profit Quality 275.52%
Current Ratio 2.05
Quick Ratio 1.31
Altman-Z 1.45
F-Score7
WACC6.9%
ROIC/WACC0.41
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A

BIO-UV GROUP SAS / ALTUV.PA FAQ

Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?

ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.


What is the valuation status for ALTUV stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.


What is the profitability of ALTUV stock?

BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.


How financially healthy is BIO-UV GROUP SAS?

The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.


What is the earnings growth outlook for BIO-UV GROUP SAS?

The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.